Research graph
References from Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and “Anagrams” Generated Potent Antituberculosis Agents. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Erotic susceptibility and tuberculosis: literary images of a pathology
10.2307/2905165 · 1990 · External reference
Unresolved reference
2011 · External reference
10.5117/9781904633037
10.5117/9781904633037 · 2005 · External reference
Tuberculosis prevention and treatment
2004 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Advent of imidazo[1,2-a]pyridine-3-carboxamides with potent multi- and extended drug resistant antituberculosis activity
10.1021/ml200036r · 2011 · External reference
Generation and exploration of new classes of antitubercular agents: the optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds
10.1016/j.bmc.2012.02.025 · 2012 · External reference
A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis
10.1371/journal.pone.0060531 · 2013 · External reference
Advancement of imidazo[1,2-a]pyridines with improved pharmacokinetics and nanomolar activity against Mycobacterium tuberculosis
10.1021/ml400088y · 2013 · External reference
Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: evidence for the functional significance of receptor subtypes
10.1016/0149-7634(94)90049-3 · 1994 · External reference
Benzodiazepine receptor binding of non-benzodiazepines in vivo: alpidem, zolpidem, and zopiclone
10.1016/0361-9230(92)90164-s · 1992 · External reference
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia
1993 · External reference
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations
10.1046/j.1365-2125.1999.00953.x · 1999 · External reference
Non-benzodiazepines for the treatment of insomnia
10.1053/smrv.2000.0126 · 2000 · External reference
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis
10.1021/cb2004884 · 2012 · External reference
Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB
10.1371/journal.pone.0052951 · 2012 · External reference
Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit
10.1016/j.neuropharm.2004.03.007 · 2004 · External reference
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
10.1038/nm.3262 · 2013 · External reference
Bactericidal activity of an imidazo[1,2-a]pyridine using a mouse M. tuberculosis infection model
10.1371/journal.pone.0087483 · 2014 · External reference
Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis
10.1039/c0mb00104j · 2010 · External reference
The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages
10.1073/pnas.97.3.1252 · 2000 · External reference
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
10.1016/j.tube.2012.07.003 · 2012 · External reference
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
10.1038/ncomms1060 · 2010 · External reference
Significance of the degree of aeration of media for the antibacterial action of antitubercular agents
1965 · External reference
Clinical significance of antitubercular agents and protein binding
1977 · External reference
Research on heterocyclic compounds. XXI. Synthesis of imidazo[2,1-b]benzothiazole and imidazo[2,1-b]thiazole derivatives
10.1002/jhet.5570240129 · 1987 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
10.1038/35016103 · 2000 · External reference
Studies on inactivation of antitubercular agents in media. III. Examination of the media with effects of inactivating antitubercular agents
1961 · External reference
A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen
10.7326/0003-4819-76-3-112-6-407 · 1990 · External reference
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis
10.1128/aac.01476-12 · 2012 · External reference
Structure–activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis
10.1021/jm900003c · 2009 · External reference
Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B
10.1128/jcm.01187-06 · 2006 · External reference
Respiratory flexibility in response to inhibition of cytochrome c oxidase in Mycobacterium tuberculosis
10.1128/aac.03486-14 · 2014 · External reference
